The ISSCR honors Dr. Kyle M. Loh with the 2026 Early Career Impact Award for Transformative Advances in Stem Cell Biology

(Press-News.org) The International Society for Stem Cell Research (ISSCR) proudly announces Kyle M. Loh, Stanford University School of Medicine, as the recipient of the 2026 ISSCR Early Career Impact Award, recognizing his transformative contributions to human pluripotent stem cell biology and his exceptional commitment to mentorship and inclusion. The award is supported by the Tianqiao and Chrissy Chen Institute, and Dr. Loh will present his work during ISSCR 2026 taking place on 8-11 July in Montréal, Canada.

“Dr. Kyle Loh exemplifies the creativity, rigor, and generosity that define the next generation of stem cell leaders,” said Hideyuki Okano, ISSCR President. “His scientific discoveries have opened new frontiers in developmental biology and disease modeling, and his dedication to mentoring young scientists reflects the values at the heart of our global community.”

Dr. Loh has redefined how scientists precisely direct human pluripotent stem cells (hPSCs) into highly purified cell types. By identifying lineage-specific progenitors and the extracellular signals that govern cell fate decisions, he developed streamlined methods to generate more than two dozen endodermal, mesodermal, and ectodermal cell types with unprecedented speed and rigor. His landmark work producing greater than 90% pure arterial and venous endothelial cells within days established a new benchmark for precision differentiation and reproducibility across laboratories worldwide.

Leveraging these advances, Loh bridged stem cell biology and virology to reveal that the lethal Nipah virus preferentially infects arterial endothelial cells – marking the first demonstration that a virus can infect a specific type of blood vessel. He has also reshaped our understanding of brain development by discovering that the forebrain/midbrain and hindbrain arise from two distinct progenitors during gastrulation, and these dual origins were conserved across more than 500 million years of evolution.

Beyond discovery, Dr. Loh’s impact extends through collaboration, rigor, and generosity. His differentiation protocols have been adopted globally, enabling advances in developmental biology and stem cell research. Equally defining is his mentorship. Drawing on his own experience as a community college student, he has personally trained students from underrepresented and minority-serving institutions, many of whom have gone on to coauthor high-impact publications and pursue advanced STEM careers. His laboratory is widely recognized for its inclusive culture and “flat” hierarchy that empowers trainees at every level.

“We also congratulate this year’s honorable mention recipients, whose bold ideas and scientific leadership are expanding the boundaries of stem cell research across neuroscience, developmental biology, organoid systems, and regenerative medicine,” added Dr. Okano. “Together, they represent the extraordinary depth and global momentum of early-career talent shaping the future of our field.”

2026 Early Career Impact Award Honorable Mentions

Faranak Fattahi, University of California, San Francisco, USA
Dr. Fattahi has pioneered human pluripotent stem cell–derived models of the peripheral nervous system, generating authentic Schwann cells, sensory neurons, and enteric nervous system organoids. Her work has provided unprecedented insight into neuropathies, gastrointestinal motility disorders, and gut–brain axis diseases, while advancing translational pipelines for drug discovery. Supported by major NIH and CIRM awards as well as foundation and private funding, her work spans both academia and industry, helping to build new infrastructure and shape emerging global standards for organoid-based neuroscience.

Kara McKinley, Harvard University and Howard Hughes Medical Institute, USA
Dr. McKinley has redefined the biology of the human endometrium, overturning a century-old structural model and establishing the uterus as a powerful system for studying scarless regeneration. Through single-cell spatial atlases and innovative mouse models of menstruation, her work illuminates mechanisms of tissue repair, cancer risk, nerve plasticity, and metabolic regulation—reshaping the landscape of reproductive and regenerative biology.

Naomi Moris and Nicolas Rivron, The Francis Crick Institute, UK / Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna BioCenter (VBC), Austria
Drs. Moris and Rivron are pioneers in stem cell–based embryo models, having developed gastruloids and blastoids that offer unprecedented access to early animal and human development. Notably, their scientific advances have been closely integrated with ethical leadership. Together with scientific societies, they actively shaped international standards for governance, methodological rigor, and responsible communication. Embedding ethical reflection into scientific endeavors contributed to building a community that couples innovation with societal responsibility, thereby enabling basic and biomedical research.

Giorgia Quadrato, USC Stem Cell, USA
Dr. Quadrato has emerged as a global leader in human brain organoid research, developing gold-standard protocols for cortical and cerebellar organoids. Her work has reshaped understanding of autism spectrum disorders by demonstrating early developmental defects in neural progenitors, redefining disease classification and therapeutic strategies. Through sustained excellence in funding, publication, and translational vision, she continues to drive innovation at the interface of neurodevelopment and regenerative medicine.

The ISSCR congratulates Dr. Kyle Loh and the 2026 Honorable Mention recipients for their extraordinary scientific achievements and leadership. Together, they represent the next generation of innovators advancing stem cell science toward deeper biological understanding and transformative impact on human health.

Learn more about all of the 2026 ISSCR Award honorees.

About ISSCR
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research is the leading global organization dedicated to advancing stem cell science and its translation to human health. 

END